Home › Business & Finance › Novartis CEO: AI Could Cut Drug Development Time by Years
Business & Finance

Novartis CEO: AI Could Cut Drug Development Time by Years

Key Points

Novartis CEO Vasant Narasimhan says artificial intelligence could help cut drug-development times from 12 years to eight and significantly improve the odds of bringing new medicines to market. Narasimhan, who also sits on Anthropic’s board, tells Bloomberg’s Francine Lacqua on "The Pulse" that AI is already helping Novartis speed up clinical trials, analyze data and identify new drug candidates. He also discusses the company’s growth outlook, drug pricing in Europe and the US, and AI regulation.

Novartis CEO Vasant Narasimhan says artificial intelligence could help cut drug-development times from 12 years to eight and significantly improve the odds of bringing new medicines to market. Narasimhan, who also sits on Anthropic’s board, tells Bloomberg’s Francine Lacqua on "The Pulse" that AI is already helping Novartis speed up clinical trials, analyze data and identify new drug candidates. He also discusses the company’s growth outlook, drug pricing in Europe and the US, and AI regulation. (Source: Bloomberg)
Novartis (ORG) AI Could Cut Drug Development Time (ORG) Vasant Narasimhan (PERSON) Narasimhan (LOCATION) Anthropic (ORG) Bloomberg (PERSON) Francine Lacqua (PERSON) AI (ORG) Europe (LOCATION) US (LOCATION)
Originally published by Bloomberg Technology Read original →